Volume 1, Issue 4 (3-2016)                   Iran J Neurosurg 2016, 1(4): 6-10 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Haddadi K. Degenerative Disc Disease: A Review of Cell Technologies and Stem Cell Therapy. Iran J Neurosurg. 2016; 1 (4) :6-10
URL: http://irjns.org/article-1-24-en.html
MD, Assistant Professor, Department of Neurosurgery, Imam Khomeini Hospital, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
Abstract:   (2511 Views)

Background & Aim: Low back pain is broadly documented as one of the most widespread pathologies in the advanced domain. Although the reasons of low back pain are uncountable, it has been meaningfully related to intervertebral disc degeneration. Present therapies for Intervertebral Disc (IVD) degeneration such as physical therapy and spinal fusion reduce symptoms' severity, but do not treat the source of degeneration. The use of tissue engineering to treat disc degeneration offers a chance to control the pathological course. New methods are presently being examined and have exposed mixed results. One major way of study has been stem cell injections. We go on to define the course of stem cell-mediated modalities in treatment of degenerative lumbar disc herniation.

Methods & Materials/Patients: Literature search was performed in electronic databases PUBMED and EMBASE by means of Mesh terminologies (Nucleus pulposus, therapeutics, annulus fibrosus, intervertebral disc) and keywords (Degenerative disk disease, Stem Cells, Therapy). Results: The intervertebral disc organization, developing treatments, mesenchymal stem cells, embryonic stem cells, practice in disc degeneration were some sections that were found in analysis for study review design.

Conclusion: Mesenchymal stem cells (MSCs) have revealed potential in small animal models, nonetheless consequences in greater vertebrates have been varied.

Full Text [PDF 386 kb]   (1230 Downloads) |   |   Full Text (HTML)  (271 Views)  
Type of Study: Research |

1. Conrad DA, Holland J, Liu J. Cost of low back pain problems: an economic analysis. Low back pain: a scientific overview. Rosemont, IL: American Academy of Orthopedic Surgeons. 1996.
2. Anderson J. Back pain and occupation. In: Jayson MIV (2). The lumbar spine and back pain. Churchill Livingstone: London. 1987;2–36.
3. Chan D, Song Y, Sham P, Cheung KM. Genetics of disc degeneration. European Spine Journal. 2006;15(3):317-25. [DOI:10.1007/s00586-006-0171-3] [PMID] [PMCID]
4. Haddadi K, Asadian L, Emadian O, Zare AH. Hydatid Disease of the Lumbar Spine: A Report on Pure Spinal Involvement With Hydatid Cysts. Neurosurgery Quarterly. 2015;25(1):128-30. [DOI:10.1097/WNQ.0000000000000007]
5. Shakeri M, Yarandi KK, Haddadi K, Sayyahmelli S. Prevalence of Abdominal Aortic Aneurysm by Magnetic Resonance Images (MRI) in Men over 50 years with low back pain. Rawal Medical Journal. 2009;34(1):1-3.
6. Ozgur BM, Aryan HE, Pimenta L, Taylor WR. Extreme Lateral Interbody Fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. The Spine Journal. 2006;6(4):435-43. [DOI:10.1016/j.spinee.2005.08.012] [PMID]
7. Song KJ, Choi BW, Jeon TS, Lee KB, Chang H. Adjacent segment degenerative disease: is it due to disease progression or a fusion-associated phenomenon? Comparison between segments adjacent to the fused and non-fused segments. European Spine Journal. 2011;20(11):1940-5. [DOI:10.1007/s00586-011-1864-9] [PMID] [PMCID]
8. Tang S, Rebholz BJ. Does anterior lumbar interbody fusion promote adjacent degeneration in degenerative disc disease? A finite element study. Journal of Orthopaedic Science. 2011;16(2):221-8. [DOI:10.1007/s00776-011-0037-3] [PMID]
9. Lotfinia I, Haddadi K, Sayyahmelli S. Computed tomographic evaluation of pedicle dimension and lumbar spinal canal. Neurosurgery Quarterly. 2010;20(3):194-8. [DOI:10.1097/WNQ.0b013e3181eb284a]
10. Thompson JP, OEGEMA TR, BRADFORD D. Stimulation of mature canine intervertebral disc by growth factors. Spine. 1991;16(3):253-60. [DOI:10.1097/00007632-199103000-00001] [PMID]
11. Gruber HE, Norton HJ, Hanley Jr EN. Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine. 2000;25(17):2153-7. [DOI:10.1097/00007632-200009010-00002] [PMID]
12. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson 3rd WF, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1996;21(3):271-7. [DOI:10.1097/00007632-199602010-00003] [PMID]
13. Hallen AN. Hexosamine and ester sulphate content of the human nucleus pulposus at different ages. Acta Chem Scand. 1958;12:1869-72. [DOI:10.3891/acta.chem.scand.12-1869]
14. Haefeli M, Kalberer F, Saegesser D, Nerlich AG, Boos N, Paesold G. The course of macroscopic degeneration in the human lumbar intervertebral disc. Spine. 2006;31(14):1522-31. [DOI:10.1097/01.brs.0000222032.52336.8e] [PMID]
15. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine. 2002;27(23):2631-44. [DOI:10.1097/00007632-200212010-00002] [PMID]
16. Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. Journal of Clinical Investigation. 1996;98(4):996. [DOI:10.1172/JCI118884] [PMID] [PMCID]
17. Freemont TJ, LeMaitre C, Watkins A, Hoyland JA. Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies. Expert reviews in molecular medicine. 2001;3(11):1-10. [DOI:10.1017/S1462399401002885]
18. Maerz T, Herkowitz H, Baker K. Molecular and genetic advances in the regeneration of the intervertebral disc. Surgical neurology international. 2013 ;4:94. [DOI:10.4103/2152-7806.109449] [PMID] [PMCID]
19. Zeckser J, Wolff M, Tucker J, Goodwin J. Multipotent Mesenchymal Stem Cell Treatment for Discogenic Low Back Pain and Disc Degeneration. Stem cells international. 2016;2016.
20. Horner HA, Urban JP. 2001 Volvo Award Winner in Basic Science Studies: effect of nutrient supply on the viability of cells from the nucleus pulposus of the intervertebral disc. Spine. 2001;26(23):2543-9. [DOI:10.1097/00007632-200112010-00006]
21. Nachemson A, Lewin T, Maroudas A, Freeman MA. In vitro diffusion of dye through the end-plates and the annulus fibrosus of human lumbar inter-vertebral discs. Acta Orthopaedica Scandinavica. 1970;41(6):589-607. [DOI:10.3109/17453677008991550] [PMID]
22. Tanaka M, Sakai D, Hiyama A, Arai F, Nakajima D, Nukaga T, et al. Effect of cryopreservation on canine and human activated nucleus pulposus cells: a feasibility study for cell therapy of the intervertebral disc. BioResearch open access. 2013;2(4):273-82. [DOI:10.1089/biores.2013.0023] [PMID] [PMCID]
23. Bibby SR, Urban JP. Effect of nutrient deprivation on the viability of intervertebral disc cells. European Spine Journal. 2004;13(8):695-701. [DOI:10.1007/s00586-003-0616-x] [PMID] [PMCID]
24. Ishihara H, Urban JP. Effects of low oxygen concentrations and metabolic inhibitors on proteoglycan and protein synthesis rates in the intervertebral disc. Journal of Orthopaedic Research. 1999;17(6):829-35. [DOI:10.1002/jor.1100170607] [PMID]
25. Coric D, Pettine K, Sumich A, Boltes MO. Prospective study of disc repair with allogeneic chondrocytes Presented at the 2012 Joint Spine Section Meeting: Clinical article. Journal of Neurosurgery: Spine. 2013;18(1):85-95. [DOI:10.3171/2012.10.SPINE12512] [PMID]
26. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. The Journal of pathology. 2004;204(1):47-54. [DOI:10.1002/path.1608] [PMID]
27. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine. 2000;25(23):3005-13. [DOI:10.1097/00007632-200012010-00007] [PMID]
28. Acosta Jr FL, Lotz J, Ames CP. The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: a critical overview. Neurosurgical focus. 2005;19(3):1-6. [DOI:10.3171/foc.2005.19.3.5]
29. Masuda K, Oegema Jr TR, An HS. Growth factors and treatment of intervertebral disc degeneration. Spine. 2004;29(23):2757-69. [DOI:10.1097/01.brs.0000146048.14946.af] [PMID]
30. An HS, Takegami K, Kamada H, Nguyen CM, Thonar EJ, Singh K, et al. Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine. 2005;30(1):25-31. [DOI:10.1097/01.brs.0000148002.68656.4d]
31. Yoon ST, Kim KS, Li J, Park JS, Akamaru T, Elmer WA, et al. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine. 2003;28(16):1773-80. [DOI:10.1097/01.BRS.0000083204.44190.34] [PMID]
32. Centeno CJ. Clinical challenges and opportunities of mesenchymal stem cells in musculoskeletal medicine. PM&R. 2014;6(1):70-7. [DOI:10.1016/j.pmrj.2013.08.612] [PMID]
33. Gorenšek M, Joksimović Č, Kregar-Velikonja NE, Gorenšek M, Knežević M, JERAS VP, et al. Nucleus pulposus repair with cultured autologous elastic cartilage derived chondrocytes. Cellular and Molecular Biology Letters. 2004;9(2):363-73. [PMID]
34. Ho G, Leung VY, Cheung KM, Chan D. Effect of severity of intervertebral disc injury on mesenchymal stem cell-based regeneration. Connective tissue research. 2008;49(1):15-21. [DOI:10.1080/03008200701818595] [PMID]
35. Steck E, Bertram H, Abel R, Chen B, Winter A, Richter W. Induction of intervertebral disc–like cells from adult mesenchymal stem cells. Stem Cells. 2005;23(3):403-11. [DOI:10.1634/stemcells.2004-0107] [PMID]
36. Shen B, Wei A, Tao H, Diwan AD, Ma DD. BMP-2 Enhances TGF-β3–Mediated Chondrogenic Differentiation of Human Bone Marrow Multipotent Mesenchymal Stromal Cells in Alginate Bead Culture. Tissue Engineering Part A. 2008;15(6):1311-20. [DOI:10.1089/ten.tea.2008.0132] [PMID]
37. Kuh SU, Zhu Y, Li J, Tsai KJ, Fei Q, Hutton WC, et al. Can TGF-β1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells?. Acta neurochirurgica. 2008;150(10):1073-9. [DOI:10.1007/s00701-008-0029-z] [PMID]
38. Hoben GM, Willard VP, Athanasiou KA. Fibrochondrogenesis of hESCs: growth factor combinations and cocultures. Stem cells and development. 2009;18(2):283-92. [DOI:10.1089/scd.2008.0024] [PMID] [PMCID]
39. Koay EJ, Hoben G, Athanasiou KA. Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells. 2007;25(9):2183-90. [DOI:10.1634/stemcells.2007-0105] [PMID]
40. Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M, Nishimura K, et al. Transplantation of mesenchymal stem cells embedded in Atelocollagen® gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials. 2003;24(20):3531-41. [DOI:10.1016/S0142-9612(03)00222-9]
41. Zhang YG, Guo X, Xu P, Kang LL, Li J. Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans. Clinical orthopaedics and related research. 2005;430:219-26. [DOI:10.1097/01.blo.0000146534.31120.cf]
42. Wei A, Tao H, Chung SA, Brisby H, Ma DD, Diwan AD. The fate of transplanted xenogeneic bone marrow derived stem cells in rat intervertebral discs. Journal of Orthopaedic Research. 2009;27(3):374-9. [DOI:10.1002/jor.20567] [PMID]
43. Takada T, Nishida K, Doita M, Kurosaka M. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine. 2002;27(14):1526-30. [DOI:10.1097/00007632-200207150-00009] [PMID]
44. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental hematology. 2002;30(1):42-8. [DOI:10.1016/S0301-472X(01)00769-X]
45. Henriksson HB, Svanvik T, Jonsson M, Hagman M, Horn M, Lindahl A, et al. Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine. 2009;34(2):141-8. [DOI:10.1097/BRS.0b013e31818f8c20] [PMID]
46. Hiyama A, Mochida J, Iwashina T, Omi H, Watanabe T, Serigano K, et al. Transplantation of mesenchymal stem cells in a canine disc degeneration model. Journal of Orthopaedic Research. 2008;26(5):589-600. [DOI:10.1002/jor.20584] [PMID]
47. Brisby H, Tao H, Ma DD, Diwan AD. Cell therapy for disc degeneration—potentials and pitfalls. Orthopedic Clinics of North America. 2004;35(1):85-93. [DOI:10.1016/S0030-5898(03)00104-4]
48. Oehme D, Goldschlager T, Ghosh P, Rosenfeld JV, Jenkin G. Cell-based therapies used to treat lumbar degenerative disc disease: a systematic review of animal studies and human clinical trials. Stem cells international. 2015;2015.
49. Handa T, Ishihara H, Ohshima H, Osada R, Tsuji H, Obata KI. Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine. 1997;22(10):1085-91. [DOI:10.1097/00007632-199705150-00006] [PMID]
50. Zhang Y, An HS, Tannoury C, Eugene JM, Freedman MK, Anderson DG.
51. Biological treatment for degenerative disc disease: implications for the field of physical medicine and rehabilitation. American Journal of Physical Medicine & Rehabilitation. 2008;87(9):694-702. [DOI:10.1097/PHM.0b013e31817c1945] [PMID]
52. Ustymenko A. M. Cell Technologies in Treatment of Human Intervertebral Disk Hernia: Perspectives. UDC 2015;611.721.1:616.34-007.43-031:611.959:616.8-08:576.32/.36

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | Iranian Journal of Neurosurgery

Designed & Developed by : Yektaweb